Position in OMER
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,123,844
+$514,796 QoQ
Shares Held
118,175
+104.9% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 172 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MML INVESTORS SERVICES, LLC holds $86,570,832 across 61 Biotechnology names. OMER ranks #18 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,907 | $19,326,274 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,117 | $11,296,674 | |
| 3 | ARGX |
Argenx SE
|
6,825 | $6,332,030 | |
| 4 | EXEL |
Exelixis, Inc.
|
73,531 | $4,000,821 | |
| 5 | INSM |
INSMED Inc
|
32,823 | $3,499,588 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,949 | $2,994,947 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,712 | $2,822,240 | |
| 8 | RPRX |
Royalty Pharma plc
|
49,942 | $2,800,247 |
All Filings in OMER
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,123,844 | 118,175 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $609,048 | 57,675 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $1,337,892 | 77,875 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $242,617 | 59,175 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $148,725 | 49,575 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $245,161 | 29,825 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $282,815 | 28,625 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $73,842 | 18,600 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $63,336 | 15,600 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||